Wednesday, Jun 18

Category: Dysautonomia

New TVAM Study Published in Acta Phlebologica

No comments
, by
Michael Arata MD of Synergy Health Concepts published the results of a new study into the safety and effectiveness of the TVAM procedure in patients with autonomic dysfunction. The study was published in the April 2014 edition of Acta Phlebologica: A Journal on Phlebology. Transvascular autonomic modulation (TVAM) is a
more

A New Approach to Treating MS Patients

No comments
, by
As MS patients are all too well aware, multiple sclerosis can cause a wide range of symptoms, from weakness and numbness to visual changes. But most MS patients don’t realize that they are very likely to have another condition known as autonomic dysfunction, or dysautonomia, and that it is dysautonomia
more

New Study Published in Acta Phlebologica

No comments
, by
Michael Arata MD of Synergy Health Concepts published the results of a new study into the safety and effectiveness of the TVAM procedure in patients with autonomic dysfunction, including patients with multiple sclerosis and other chronic conditions. The study was published in the April 2014 edition of Acta Phlebologica: A
more

Dr. Arata Presents Results of New Study at ISET

No comments
, by
The results of Synergy’s new study were released today at the International Symposium on Endovascular Therapy (ISET). The study, which can be found here, investigates whether balloon angioplasty induces alterations in the hypothalamus pituitary adrenal (HPA) axis as indicated by changes in levels of ACTH and Cortisol. 88 patients in
more

Studies Investigate Relationship Between New Treatment and Reduction in Dysautonomia Symptoms in MS Patients

No comments
, by
Synergy Health has published a new study, the first in a series, investigating the relationship between treatment for CCSVI (and its successor treatment, TVAM therapy) and the improvement of the symptoms of dysautonomia among M.S. Patients and other groups suffering from autonomic dysfunction. Read our latest study here: http://phl.sagepub.com/content/early/2020/11/18 While
more

A Promising New Treatment for Dysautonomia Patients

No comments
, by
Most patients diagnosed with isolated or “pure” dysautonomia – autonomic dysfunction with no underlying neurological condition – generally first seek medical treatment for cardiovascular issues, such as POTS (where the heart rate fluctuates based on body position) or syncope (the tendency to pass out frequently). As a result, dysautonomia is
more

The Current Status of CCSVI Treatment

No comments
, by
Since the condition known as chronic cerebrospinal venous insufficiency (CCSVI) was first described by Dr. Paolo Zamboni in 2008, the relationship between this condition and MS has been investigated and rigorously debated. Yet while Zamboni’s original study saw an over 90% correlation between MS and CCSVI, later studies have cast
more

Solving the CCSVI Puzzle

No comments
, by
CCSVI, as described by Zamboni, is a disturbance of the central nervous system (CNS) venous drainage. The impaired venous drainage seen with CCSVI was postulated to have an effect on multiple sclerosis. Based on the theory of CCSVI, treatment of jugular venous insufficiency has been studied as a potential therapeutic
more

BNAC

No comments
, by
CCSVI is one of the most controversial topics in modern medical history. CCSVI is held in particular disdain within the neurologic community. University of Buffalo researchers issued a press release regarding their study of CCSVI on March 15th, which was followed shortly by the annual meeting of the American Academy
more

10 Integrative Care Principles for Dysautonomia

No comments
, by
Integrative care is fundamental to treating dysautonomia, and you are responsible for making sure it is in place and working. The dedication and expertise required by the proceduralist and associated specialists, such as naturopaths and chiropractors, is important, but does not obviate the patient’s personal responsibility for health. You and
more